APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 512-519

  Jang, Yangsoo ^a,b   Chae, Jey Sook ^a   Kim, Oh Yoen ^a   Park, Hey Jun ^a   Kim, Ji Young ^a   Paik, Jean Kyung ^a   Lee, Sang Hyun ^c   Lee, Jong Ho ^a,c  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c National Health Insurance Corporation   (South Korea)

Author keywords

APOA5 1131 T>C; Apolipoprotein A5; Dietary intervention and regular exercise; Hypertriglyceridemia; Triglycerides

Indexed keywords

APOLIPOPROTEIN A5; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; DIET THERAPY; EXERCISE; FEMALE; GENOTYPE; GROUPS BY AGE; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; VEGETABLE; WEIGHT CHANGE;

ADULT; ANTHROPOMETRY; APOLIPOPROTEINS A; CHOLESTEROL; CHOLESTEROL, HDL; DIET; EXERCISE; FEMALE; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; KOREA; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 77955276393     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.03.014     Document Type: Article

References (37)

1. Le N.A., Walter M.F. The role of hypertriglyceridemia in atherosclerosis. Curr Atheroscler Rep 2007, 9:110-115.
2. Chug H.K., Chae J.S., Hyun Y.J., et al. Influence of adiponectin gene polymorphisms on adiponectin level and insulin resistance index in response to dietary intervention in overweight-obese patients with impaired fasting glucose or newly diagnosed type 2 diabetes. Diabetes Care 2009, 32:552-558.
3. Zhan S., Ho S.C. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 2005, 81:397-408.
4. Pennacchio L.A., Olivier M., Hubacek J.A., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294:169-173.
5. Fruchart-Najib J., Baugé E., Niculescu L.S., et al. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem Biophys Res Commun 2004, 319:397-404.
6. van der Vliet H.N., Schaap F.G., Levels J.H., et al. Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochem Biophys Res Commun 2002, 295:1156-1159.
7. Talmud P.J., Martin S., Taskinen M.R., et al. APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res 2004, 45:750-756.
8. Dorfmeister B., Cooper J.A., Stephens J.W., et al. The effect of APOA5 and APOC3 variants on lipid parameters in European whites, Indian Asians and Afro-Caribbeans with type 2 diabetes. Biochim Biophys Acta 2007, 1772:355-363.
9. Pennacchio L.A., Olivier M., Hubacek J.A., et al. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 2002, 11:3031-3038.
10. Nabika T., Nasreen S., Kobayashi S., Masuda J. The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis 2002, 165:201-204.
11. Jang Y., Kim J.Y., Kim O.Y., et al. The -1131T→C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia, elevated small, dense LDL concentrations, and oxidative stress in nonobese Korean men. Am J Clin Nutr 2004, 80:832-840.
12. Jang Y., Paik J.K., Hyun Y.J., et al. The apolipoprotein A5-1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations. LDL particle size and coronary artery disease. Clin Chim Acta 2009, 402:83-87.
13. Talmud P.J., Hawe E., Martin S., et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 2002, 11:3039-3046.
14. Korea Centers for Disease Control Prevention The Third Korea National Health and Nutrition Examination Survey (KNHANES III) 2005, Korea Centers for Disease Control and Prevention, Seoul, South Korea.
15. The Expert Panel on Detection Evaluation Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
16. Shim J.S., Oh K.W., Suh I., et al. A study on validity of a 299 semiquantitative food frequency questionnaire of Korean adults. Korean J Community Nutr 2002, 7:484-494.
17. Christian J.L., Greger J.L. Nutrition for living 1994, Benjamin/Cummings, Redwood City, CA, p. 111.
18. The American Dietetic Association Handbook of clinical dietetics 1992, Yale University Press, New Haven, CT, pp. 5-39. 2nd ed.
19. Lai C.Q., Tai E.S., Tan C.E., et al. The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 2003, 44:2365-2373.
20. Corella D., Lai C.Q., Demissie S., et al. APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. J Mol Med 2007, 85:119-128.
21. Chandak G.R., Ward K.J., Yajnik C.S., et al. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans. BMC Med Genet 2006, 7:76.
22. Lai C.Q., Parnell L.D., Ordovas J.M. The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk. Curr Opin Lipidol 2005, 16:153-166.
23. Dallongeville J., Cottel D., Wagner A., et al. The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides. BMC Med Genet 2008, 9(84):1-9.
24. Hyun Y.J., Jang Y., Chae J.S., et al. Association of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men. Atherosclerosis 2009, 205:568-573.
25. Aberle J., Evans D., Beil F.U., Seedorf U. A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet. Clin Genet 2005, 68:152-154.
26. Hubacek J.A., Adamkova V., Prusikova M., et al. Impact of apolipoprotein A5 variants on statin treatment efficacy. Pharmacogenomics 2009, 10:945-950.
27. Suchanek P., Lorenzova A., Poledne R., Hubacek J.A. Changes of plasma lipids during weight reduction in females depends on APOA5 variants. Ann Nutr Metab 2008, 53:104-108.
28. Kim J.Y., Kim O.Y., Koh S.J., et al. Comparison of low-fat meal and high-fat meal on postprandial lipemic response in non-obese men according to the -1131T>C polymorphism of the apolipoprotein A5 (APOA5) gene (randomized cross-over design). J Am Coll Nutr 2006, 25:340-347.
29. Schaap F.G., Rensen P.C., Voshol P.J., et al. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 2004, 279:27941-27947.
30. Tai E.S., Ordovas J.M. Clinical significance of apolipoprotein A5. Curr Opin Lipidol 2008, 19:349-354.
31. Marçais C., Verges B., Charrière S., et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest 2005, 115:2862-2869.
32. Perez-Martinez P., Corella D., Shen J., et al. Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states. Am J Clin Nutr 2009, 9:391-399.
33. Endo K., Yanagi H., Araki J., et al. Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese school children. Hum Genet 2002, 111:570-572.
34. Martin S., Nicaud V., Humphries S.E., Talmud P.J. Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochim Biophys Acta 2003, 1637:217-225. EARS group.
35. Talmud P.J., Palmen J., Putt W., Lins L., Humphries S.E. Determination of the functionality of common APOA5 polymorphisms. J Biol Chem 2005, 280:28215-28220.
36. van der Vliet H.N., Sammels M.G., Leegwater A.C., et al. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 2001, 276:44512-44520.
37. Rimm E.B., Giovannucci E.L., Stampfer M.J., et al. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992, 135:1114-1126.